台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP05-07: Hyperthermia inhibits chemotherapeutic drug resistance of bladder cancer cells through epithelial mesenchymal transition down-regulation

2021-05-24 • 觀看: 1479 • 回應: 0 • doc
MP05-06: External validation of Likert scale for predicting non-muscle invasive bladder cancer, KCGMH experience

2021-05-24 • 觀看: 1411 • 回應: 0 • doc
MP05-05: Cadherin-11 regulates cell pyroptosis and induces anti-tumor immunity through PD-L1 in bladder cancer

2021-05-24 • 觀看: 1543 • 回應: 0 • doc
MP05-04: The attenuation of chloroquine and hydroxychloroquine on the invasive potential of bladder cancer by targeting MMP-2 expression

2021-05-24 • 觀看: 1527 • 回應: 0 • doc
MP05-03: Small non-coding microRNAs (miRNAs) target hepatoma-derived growth factor (HDGF) as a novel therapeutic strategy for urothelial carcinoma

2021-05-24 • 觀看: 1723 • 回應: 0 • doc
MP05-02: PR-619, an inhibitor of deubiquitylating enzymes, reverses drug resistance in cisplatin-resistant urothelial carcinoma cells via suppression of c-myc

2021-05-24 • 觀看: 1614 • 回應: 0 • doc
MP05-01: The prognostic impact of tumour architecture for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis

2021-05-24 • 觀看: 1538 • 回應: 0 • doc
MP04-10: Strangulated urethral prolapse occurring in a patient being treated for central precocious puberty

2021-05-24 • 觀看: 1745 • 回應: 0 • doc
MP04-09: The role of PRP injection in the prophylaxis of recurrent UTI in women-any predictive factor?

2021-05-24 • 觀看: 1809 • 回應: 0 • doc
MP04-08: The effect of uric acid on the calcium oxalate crystallization

2021-05-24 • 觀看: 1530 • 回應: 0 • doc
MP04-07: Obesity-related indices and its association with kidney stone

2021-05-24 • 觀看: 1367 • 回應: 0 • doc
MP04-06: The association between phthalate levels in urine and urinary uric acid

2021-05-24 • 觀看: 1503 • 回應: 0 • doc

Prev
687
688
689
690
691
692
693
694
695
696
Next
/ 1262